HLB bioStep Co.,Ltd.
Research HLB bioStep Co.,Ltd. (278650.KQ) on Bullrun: market cap KRW 91.01B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker278650.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryBiotechnology
- CurrencyKRW
- Market capKRW 91.01B
- Financial periodQ2 2026
- RevenueKRW 15.97B
- Net income-KRW 3.42B
- Free cash flow-KRW 2.10B
- Gross margin67.8%
Valuation Snapshot
latest market cap is KRW 91.01B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 91.01B | n/a | n/a | n/a |
About HLB bioStep Co.,Ltd.
HLB bioStep Co.,Ltd. provides various test services in South Korea. It offers non clinical CRO services for cancer, bone and brain disease, endocrineand metabolic and eye disease, liver and circulatory system disease, dental and gastrointestinal disease, hair growth, kidney and respiratory disease, painmodel, and skin disease. It also offers representative analysis equipment, veterinary drug development consulting and clinical trial services, and bioanalysis items. The company was formerly known as KNOTUS Co.,Ltd.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is HLB bioStep Co.,Ltd.'s market cap?
HLB bioStep Co.,Ltd.'s market capitalization is KRW 91.01B.
What does HLB bioStep Co.,Ltd. do?
HLB bioStep Co.,Ltd. provides various test services in South Korea. It offers non clinical CRO services for cancer, bone and brain disease, endocrineand metabolic and eye disease, liver and circulatory system disease, dental and gastrointestinal disease, hair growth, kidney and respiratory disease, painmodel, and skin disease. It also offers representative analysis equipment, veterinary drug development consulting and clinical trial services, and bioanalysis items. The company was formerly known as KNOTUS Co.,Ltd. HLB bioStep Co.,Ltd.